Susquehanna International Group, LLP Arcturus Therapeutics Holdings Inc. Transaction History
Susquehanna International Group, LLP
- $688 Billion
- Q2 2025
A detailed history of Susquehanna International Group, LLP transactions in Arcturus Therapeutics Holdings Inc. stock. As of the latest transaction made, Susquehanna International Group, LLP holds 122,613 shares of ARCT stock, worth $1.83 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
122,613
Previous 57,401
113.61%
Holding current value
$1.83 Million
Previous $607,000
162.77%
% of portfolio
0.0%
Previous 0.0%
Shares
25 transactions
Others Institutions Holding ARCT
# of Institutions
166Shares Held
25.8MCall Options Held
339KPut Options Held
102K-
Federated Hermes, Inc. Pittsburgh, PA4.69MShares$69.9 Million0.12% of portfolio
-
Black Rock Inc. New York, NY2.65MShares$39.5 Million0.0% of portfolio
-
Sumitomo Mitsui Trust Holdings, Inc.1.83MShares$27.3 Million0.02% of portfolio
-
Nikko Asset Management Americas, Inc.1.83MShares$27.3 Million0.25% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.81MShares$27 Million0.0% of portfolio
About Arcturus Therapeutics Holdings Inc.
- Ticker ARCT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 26,576,400
- Market Cap $396M
- Description
- Arcturus Therapeutics Holdings Inc., an RNA medicines company, focuses on the development of vaccines for infectious, and liver and respiratory rare diseases in the United States. The company's development programs comprise LUNAR-OTC development program for ornithine transcarbamylase (OTC) deficiency; and LUNAR-CF program for cystic fibrosis lun...